Choksi Laboratories share news and announcements
BSE: 526546Healthcare ServicesSmall Cap
Last close ₹207.75down ₹1.45 (0.69%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹209.20.
52-week range of traded prices to 23 Oct 2026
₹81.85Low, 4 Mar 2026₹226.65High, 15 Oct 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹145 Cr3,091st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 13 Aug 2026
- 66.9
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹0.78 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 104.6
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 25 May 2026
- 5.7
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 13 Aug 2026
- 8.8%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹0.78 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 5.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 13 Aug 2026
- 9.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 25 May 2026
- 1.18
- Volume, BSEVolume. Shares traded on the last trading day.
- 5,361
Choksi Laboratories routine notices
66 filed, newest first. Page 2 of 2.
Nov 2017
Sep 2017
Aug 2017
Feb 2017
Nov 2016
Sep 2016
Aug 2016
May 2016
19 May · Routine
Meeting of the Board of Directors of the Company will be held on May 28, 2016 to consider inter-alia audited financial results of the Company ....
Mar 2016
10 Mar · Routine
Meeting of the Board of Directors of the Company will be held on March 21, 2016. Also pursuant to SEBl (Prohibition of Insider Trading] ....
Oct 2015
19 Oct · Routine
Meeting of the Board of Directors of the Company will be held on November 03, 2015, inter alia, to consider unaudited financial results of ....
Aug 2015
4 Aug · Routine
Meeting of the Board of Directors of the Company will be held on August 13, 2015, inter alia, to consider the unaudited financial results ....
May 2015
21 May · Routine
Meeting of the Board of Directors of the Company will be held on May 30, 2015, inter alia, to consider the audited financial results of the ....
Feb 2015
6 Feb · Routine
Meeting of the Board of Directors of the Company will be held on February 14, 2015, inter alia, to consider the un-audited financial results ....
Nov 2014
6 Nov · Routine
Meeting of the Board of Directors of the Company will be held on November 14, 2014, inter alia, to consider un-audited financial results ....
Aug 2014
4 Aug · Routine
Meeting of the Board of Directors of the Company will be held on August 12, 2014, inter alia, to consider un-audited financial results of ....
May 2014
21 May · Routine
Meeting of the Board of Directors of the Company will be held on May 30, 2014, inter alia, to consider audited financial results of the Company ....